Published in J Bone Metab on May 31, 2014
Oral Bisphosphonate and Risk of Esophageal Cancer: A Nationwide Claim Study. J Bone Metab (2015) 0.80
Undertreatment of osteoporosis following hip fractures in jeju cohort study. J Bone Metab (2014) 0.77
Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis? J Bone Metab (2016) 0.75
Physicians' perspectives on the treatment of osteoporosis patients with bisphosphonates. Clin Interv Aging (2016) 0.75
Influence of gastrointestinal events on treatment of osteoporosis in Asia-Pacific women: Perspectives from physicians in the MUSIC OS-AP study. Bone Rep (2017) 0.75
Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med (2010) 6.47
Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med (2011) 6.44
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2013) 5.76
Osteoporosis: a still increasing prevalence. Bone (2006) 2.89
The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med (2006) 2.78
Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res (2009) 2.65
Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int (2006) 2.37
Incidence and mortality following hip fracture in Korea. J Korean Med Sci (2011) 2.11
Osteoporosis management and the utilization of FRAX®: a survey amongst health care professionals of the Asia-Pacific. Arch Osteoporos (2012) 2.05
Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc (2002) 1.99
The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab (2011) 1.88
Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry. Osteoporos Int (2012) 1.84
Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med (2012) 1.80
Mortality after vertebral fracture in Korea: analysis of the National Claim Registry. Osteoporos Int (2011) 1.51
The societal burden of osteoporosis in Sweden. Bone (2007) 1.43
Calcium supplements and cardiovascular risk in the Women's Health Initiative. Osteoporos Int (2013) 1.42
The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol (2007) 1.37
Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas (2013) 1.34
BMD, clinical risk factors and their combination for hip fracture prevention. Osteoporos Int (2009) 1.12
Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. J Intern Med (2006) 1.06
Bisphosphonate use and subsequent hip fracture in South Korea. Osteoporos Int (2013) 1.02
Vitamin D status and bone turnover in women with acute hip fracture. Clin Orthop Relat Res (2004) 0.98
AACE Clinical Practice Guidelines for the Prevention and Treatment of Postmenopausal Osteoporosis. J Fla Med Assoc (1996) 0.87
Optimal serum concentration of 25-hydroxyvitamin D for bone health in older Korean adults. Calcif Tissue Int (2012) 0.87
Cardiovascular effects of calcium supplements. Nutrients (2013) 0.86
Prevention of fractures in older people with calcium and vitamin D. Nutrients (2010) 0.86
Influence of the vitamin D receptor alleles on human osteoblast-like cells. J Bone Joint Surg Br (2001) 0.84
Report of the International Society for Clinical Densitometry 2007 Adult Position Development Conference and Official Positions. South Med J (2008) 0.84
FRAX and the assessment of the risk of developing a fragility fracture. J Bone Joint Surg Br (2012) 0.82
Implementation of and compliance with NICE guidelines in the secondary prevention of osteoporotic fractures in postmenopausal women. Ann R Coll Surg Engl (2008) 0.80
Mortality after hip fractures in nonagenarians. J Bone Metab (2012) 0.97
Which Bisphosphonate? It's the Compliance!: Decision Analysis. J Bone Metab (2016) 0.96
National utilization of calcium supplements in patients with osteoporotic hip fracture in Korea. J Bone Metab (2013) 0.91
Ultrasound-guided Prolotherapy with Polydeoxyribonucleotide Sodium in Ischiofemoral Impingement Syndrome. Pain Pract (2014) 0.89
Osteoporotic Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research. J Bone Metab (2015) 0.89
National trends of hip arthroscopy in Korea. J Korean Med Sci (2014) 0.88
National healthcare budget impact analysis of the treatment for osteoporosis and fractures in Korea. J Bone Metab (2013) 0.87
Osteoporotic Fracture Risk Assessment Using Bone Mineral Density in Korean: A Community-based Cohort Study. J Bone Metab (2016) 0.86
National trends of surgical treatment for intertrochanteric fractures in Korea. J Korean Med Sci (2013) 0.86
Prevalence of Sarcopenia Adjusted Body Mass Index in the Korean Woman Based on the Korean National Health and Nutritional Examination Surveys. J Bone Metab (2016) 0.82
A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model. J Bone Metab (2015) 0.81
Validation of a new food frequency questionnaire for assessment of calcium and vitamin d intake in korean women. J Bone Metab (2013) 0.81
Risk of hip fractures in men with alpha-blockers: a nationwide study base on claim registry. J Bone Metab (2015) 0.81
Knowledge on osteoporosis of prescriber according to level of medical institute. Yonsei Med J (2014) 0.81
Inadequate Dietary Calcium and Vitamin D Intake in Patients with Osteoporotic Fracture. J Bone Metab (2016) 0.79
Arthroscopic Treatment of Symptomatic Internal Snapping Hip with Combined Pathologies. Clin Orthop Surg (2015) 0.79
Utilization of Hyaluronate and Incidence of Septic Knee Arthritis in Adults: Results from the Korean National Claim Registry. Clin Orthop Surg (2015) 0.78
Characteristics of Patients Diagnosed with Osteoporosis in South Korea: Results from the National Claim Registry. J Bone Metab (2017) 0.77
Undertreatment of osteoporosis following hip fractures in jeju cohort study. J Bone Metab (2014) 0.77
Patient satisfaction after arthroscopic repair of acetabular labral tears. Clin Orthop Surg (2014) 0.76
Lower Urinary Tract Infection and Periprosthetic Joint Infection after Elective Primary Total Hip Arthroplasty. Hip Pelvis (2017) 0.75
Bone health and clinical results after hip fracture surgery in patients with subclinical hypothyroidism. J Bone Metab (2014) 0.75
Correlation of Structural Bony Abnormalities and Mechanical Symptoms of Hip Joints. Hip Pelvis (2014) 0.75
Hypertrophic osteoarthropathy in patient with Crohn's disease: a case report. J Bone Metab (2014) 0.75
Health-related Quality of Life in Accordance with Fracture History and Comorbidities in Korean Patients with Osteoporosis. J Bone Metab (2016) 0.75
Advantage of minimal anterior knee pain and long-term survivorship of cemented single radius posterior-stabilized total knee arthroplasty without patella resurfacing. Clin Orthop Surg (2015) 0.75
Contemporary ceramic total hip arthroplasty in patients with cerebral palsy: does it work? Clin Orthop Surg (2015) 0.75
High Levels of Heavy Metals Increase the Prevalence of Sarcopenia in the Elderly Population. J Bone Metab (2016) 0.75
Current trends of stem use in hemiarthroplasty for femoral neck fracture in South Korea. Clin Orthop Surg (2014) 0.75
Incidence, Morbidity and Mortality in Patients Older than 50 Years with Second Hip Fracture in a Jeju Cohort Study. Hip Pelvis (2014) 0.75
Fracture Preventing Effects of Maxmarvil® Tablets (Alendronate 5 mg + Calcitriol 0.5 µg) in Patients with Osteoporosis. J Bone Metab (2017) 0.75
The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis. J Bone Metab (2017) 0.75
Vitamin D Deficiency Is Highly Concomitant but Not Strong Risk Factor for Mortality in Patients Aged 50 Year and Older with Hip Fracture. J Bone Metab (2015) 0.75
Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis? J Bone Metab (2016) 0.75
Evidence-based guidelines for fall prevention in Korea. Korean J Intern Med (2017) 0.75
Erratum to: Vitamin D Deficiency Is Highly Concomitant but Not Strong Risk Factor for Mortality in Patients Aged 50 Year and Older with Hip Fracture. J Bone Metab (2016) 0.75
Conservative Treatment for Minimally Displaced Type B Periprosthetic Femoral Fractures. J Arthroplasty (2017) 0.75
Low calcium and vitamin D intake in Korean women over 50 years of age. J Bone Miner Metab (2016) 0.75
Economic Burden of Osteoporosis in South Korea: Claim Data of the National Health Insurance Service from 2008 to 2011. Calcif Tissue Int (2017) 0.75
Management of Blood Loss in Hip Arthroplasty: Korean Hip Society Current Consensus. Hip Pelvis (2017) 0.75
Change of Bone Mineral Density Measurement among Patients with Osteoporotic Fractures in Korean Population Using National Claim Database. J Bone Metab (2017) 0.75
Do Cementless Short Tapered Stems Reduce the Incidence of Thigh Pain After Hip Arthroplasty? Systematic Review and Meta-Analysis. J Korean Med Sci (2022) 0.75
Domestic Characteristics and Trends of Publications on Bone Metabolism in South Korea between 1998 and 2012. J Bone Metab (2013) 0.75
Healthcare Costs of Osteoporotic Fracture in Korea: Information from the National Health Insurance Claims Database, 2008-2011. J Bone Metab (2017) 0.75
Factors Associated with the Risk of Articular Surface Perforation during Anchor Placement for Arthroscopic Acetabular Labral Repair. Clin Orthop Surg (2017) 0.75